Young Kee Shong - Search Results

Year	Number of Results
1983	1
2003	3
2004	5
2005	5
2006	4
2007	4
2008	5
2009	5
2010	6
2011	9
2012	9
2013	12
2014	21
2015	32
2016	28
2017	31
2018	26
2019	27
2020	20
2021	14
2022	9
2023	8
2024	1

1

Undercover active surveillance of small highly suspicious thyroid nodules without fine needle aspiration.

Kim CA, Yoo J, Oh HS, Jeon MJ, Chung SR, Baek JH, Kim WB, Shong YK, Kim WG. Kim CA, et al. Among authors: shong yk. Endocrine. 2024 May;84(2):615-624. doi: 10.1007/s12020-023-03601-6. Epub 2023 Nov 23. Endocrine. 2024. PMID: 37995012

2

Changes in peripheral blood immune cell population in thyroid cancer patients treated with lenvatinib.

Jin M, Kim CA, Bae DJ, Kim SY, Kim TY, Kim WB, Shong YK, Kim WG, Jeon MJ. Jin M, et al. Among authors: shong yk. Sci Rep. 2023 Aug 7;13(1):12765. doi: 10.1038/s41598-023-39503-w. Sci Rep. 2023. PMID: 37550394 Free PMC article.

3

Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib.

Jin M, Kim M, Jeon MJ, Kim EY, Shin DY, Kim BH, Kim WB, Shong YK, Lim DJ, Kim WG. Jin M, et al. Among authors: shong yk. Endocrine. 2023 Aug;81(2):298-305. doi: 10.1007/s12020-023-03348-0. Epub 2023 Mar 16. Endocrine. 2023. PMID: 36928602

4

Serum thyroglobulin testing after thyroid lobectomy in patients with 1-4 cm papillary thyroid carcinoma.

Jang A, Jin M, Kim CA, Jeon MJ, Lee YM, Sung TY, Kim TY, Kim WB, Shong YK, Kim WG. Jang A, et al. Among authors: shong yk. Endocrine. 2023 Aug;81(2):290-297. doi: 10.1007/s12020-023-03346-2. Epub 2023 Mar 13. Endocrine. 2023. PMID: 36913171

5

Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort.

Jin M, Jang A, Kim CA, Kim TY, Kim WB, Shong YK, Jeon MJ, Kim WG. Jin M, et al. Among authors: shong yk. Eur Thyroid J. 2023 Mar 17;12(2):e220226. doi: 10.1530/ETJ-22-0226. Print 2023 Apr 1. Eur Thyroid J. 2023. PMID: 36826832 Free PMC article.

6

2021 Asia-Pacific Graves' Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves' Disease.

Parameswaran R, de Jong MC, Kit JLW, Sek K, Nam TQ, Thang TV, Khue NT, Aye TT, Tun PM, Cole T, Miller JA, Villa M, Khiewvan B, Sirinvaravong S, Sin YL, Muhammad R, Jap TS, Agrawal A, Rajput R, Fernando R, Sumanatilleke M, Suastika K, Shong YK, Lang B, Bartalena L, Yang SP; Asian Graves Consortium Study. Parameswaran R, et al. Among authors: shong yk. Endocrine. 2023 Jan;79(1):135-142. doi: 10.1007/s12020-022-03193-7. Epub 2022 Sep 21. Endocrine. 2023. PMID: 36129592

7

Prognosis of Patients with 1-4 cm Papillary Thyroid Cancer Who Underwent Lobectomy: Focus on Gross Extrathyroidal Extension Invading Only the Strap Muscles.

Jang A, Jin M, Kim WW, Jeon MJ, Sung TY, Song DE, Kim TY, Chung KW, Kim WB, Shong YK, Lee YM, Kim WG. Jang A, et al. Among authors: shong yk. Ann Surg Oncol. 2022 Nov;29(12):7835-7842. doi: 10.1245/s10434-022-12155-2. Epub 2022 Jul 30. Ann Surg Oncol. 2022. PMID: 35907995

8

Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study.

Kim M, Jin M, Jeon MJ, Kim EY, Shin DY, Lim DJ, Kim BH, Kang HC, Kim WB, Shong YK, Kim HK, Kim WG. Kim M, et al. Among authors: shong yk. Thyroid. 2023 Jan;33(1):91-99. doi: 10.1089/thy.2022.0054. Epub 2022 May 17. Thyroid. 2023. PMID: 35443825

9

Limitations of fine-needle aspiration and core needle biopsies in the diagnosis of tall cell variant of papillary thyroid carcinoma.

Ahn J, Jin M, Kim WG, Kim TY, Kim WB, Shong YK, Baek JH, Song DE, Jeon MJ. Ahn J, et al. Among authors: shong yk. Clin Endocrinol (Oxf). 2023 Jan;98(1):110-116. doi: 10.1111/cen.14735. Epub 2022 Apr 17. Clin Endocrinol (Oxf). 2023. PMID: 35394662

10

Effects of dabrafenib and erlotinib combination treatment on anaplastic thyroid carcinoma.

Choi YS, Kwon H, You MH, Kim TY, Kim WB, Shong YK, Jeon MJ, Kim WG. Choi YS, et al. Among authors: shong yk. Endocr Relat Cancer. 2022 May 9;29(6):307-319. doi: 10.1530/ERC-22-0022. Endocr Relat Cancer. 2022. PMID: 35343921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

241 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Results by year